ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

OBSTRUCTIVE SLEEP APNEA (OSA) MANAGEMENT: SYSTEMATIC REVIEW IN LITERATURE

AUTHORS:

Alaa Alanazi , Salem Alsohaimi , Fayez Alruwaili , Abdulaziz AlSudairi , Mohammed Algarni , Tamam Alshammari , Abdullah Alhomaidhi , Khulud Alqahtani , Hager Alqahtani , Raed Hashem

ABSTRACT:

This review is aiming to systematically summarize and compare the literature on Obstructive sleep apnea. The present review was conducted by searching in Medline, Embase, Web of Science, Science Direct, BMJ journal and Google Scholar for, researches, review articles and reports, published over the past years. Books published on management Obstructive sleep apnea. If several studies had similar findings, we randomly selected one or two to avoid repetitive. Based on findings and results this review found that there is Different management options are now available for an effective management of this disease. Based on multidisciplinary approach and combination of treatments like and the basic one is the continuous positive airway pressure (CPAP) is still recognized as the gold standard treatment. Nasal CPAP (nCPAP) is highly effective in controlling symptoms, improving quality of life and reducing the clinical sequelae of sleep apnea. Mandibular advancement devices, particularly if custom made, are effective in mild to moderate OSA and provide a viable alternative for patients intolerant to CPAP therapy. In addition to the Alternative options include weight control, mandibular advancement devices and a number of upper airway surgical approaches. Keywords: Obstructive sleep apnea (OSA), managements, Continuous positive airway pressure, weight loss Abbreviations used in this paper:OSA: Obstructive sleep apnea CPAP: continuous positive airway pressure, nCPAP: Nasal continuous positive airway pressure CPAP, AHI: apnoea-hypopnoea index.

FULL TEXT

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.